Education Lab/CME

Ace the Case: A 57-Year-Old Woman Who Has Gained and Lost Weight
CMEABIM MOC

Ace the Case: A 57-Year-Old Woman Who Has Gained and Lost Weight

There is no commercial support for this activity.

Expiration Date: 12/14/2018
Credit Type(s): CME / ABIM MOC | Credit: 0.25

This “Ace the Case” study will discuss the discuss the management of obesity in a 57-year old woman. Accurately assess the appropriate treatment option(s) for this…

go to activity »
Practical Lipidology® (Volume 4): Focus on: LDL Reduction and PCSK9 Inhibition
CME

Practical Lipidology® (Volume 4): Focus on: LDL Reduction and PCSK9 Inhibition

This activity is supported by an educational grant from Amgen, Inc.

Expiration Date: 10/23/2018
Credit Type(s): CME | Credit: 1.25

The reduction of low-density lipoprotein cholesterol (LDL-C) is recognized as the primary strategy for decreasing cardiovascular risk. Despite highly effective statin…

go to activity »
Innovations in Insulin: New Opportunities to Individualize Therapy
CMECE

Innovations in Insulin: New Opportunities to Individualize Therapy

Presented by the Annenberg Center for Health Sciences.
This activity is supported by an independent educational grant from Novo Nordisk Inc.
This activity is supported by an educational grant from Lilly.

Expiration Date: 4/12/2018
Credit Type(s): CME / CE | Credit: 1.5

Vivian A. Fonseca, MD, and Jonathan D. Leffert, MD, combine their expertise and discuss emerging concepts, treatment advancements, and critical issues associated with…

go to activity »
Understanding and Managing a Complex Dual Dilemma: Diabetes and Dyslipidemia
CMEABIM MOC

Understanding and Managing a Complex Dual Dilemma: Diabetes and Dyslipidemia

This activity is supported by an educational grant from Amgen.

Expiration Date: 10/19/2018
Credit Type(s): CME / ABIM MOC | Credit: 1.25

Patients with type 2 diabetes have increased cardiovascular risk. Inhibitors of proprotein convertase subtilisin/kexin type 9 (PCSK9) have emerged as effective…

go to activity »
Practical Lipidology® Volume 4, Number 1: Focus on LDL Reduction and PCSK9 Inhibition
CME

Practical Lipidology® Volume 4, Number 1: Focus on LDL Reduction and PCSK9 Inhibition

This activity is supported by an educational grant from Amgen

Expiration Date: 6/30/2018
Credit Type(s): CME | Credit: 1.25

A preponderance of data shows that low-density lipoprotein cholesterol (LDL-C) plays a causal role in atherosclerotic cardiovascular disease. Despite highly effective…

go to activity »
What You Need to Know About Familial Chylomicronemia Syndrome: Pathophysiology, Diagnosis, Management, and the Patient Perspective
CMECNECPE

What You Need to Know About Familial Chylomicronemia Syndrome: Pathophysiology, Diagnosis, Management, and the Patient Perspective

This activity is supported by an educational grant from Akcea Therapeutics™ A Subsidiary of Ionis Pharmaceuticals, Inc.
Endorsed by: The National Lipid Association.

Expiration Date: 5/15/2018
Credit Type(s): CNE / CME / CPE | Credit: 1

Familial chylomicronemia syndrome (FCS) is a rare genetic disease that leads to severe hypertriglyceridemia and recurrent episodes of acute pancreatitis. Due to its…

go to activity »
Ace the Case: A 39-Year-Old Man with Progressive Weight Gain
CMEABIM MOC

Ace the Case: A 39-Year-Old Man with Progressive Weight Gain

No commercial support for this activity.

Expiration Date: 11/14/2018
Credit Type(s): ABIM MOC / CME | Credit: 0.25

This “Ace the Case” activity will use a case study to discuss obesity management in a patient with progressive weight gain accelerated over the past year….

go to activity »
Best of Obesity Forum® 2017
CME

Best of Obesity Forum® 2017

This activity is supported by an educational grant from Novo Nordisk, Inc.

Expiration Date: 11/12/2018
Credit Type(s): CME | Credit: 1.75

The incidence of obesity has increased dramatically over the past 20 years and is considered to be an epidemic in the United States. According to the US Centers for…

go to activity »
Early Treatment of Diabetic Retinopathy and Diabetic Macular Edema: Optimal Use of Anti-VEGF Therapy for Vision Preservation and Restoration
CME

Early Treatment of Diabetic Retinopathy and Diabetic Macular Edema: Optimal Use of Anti-VEGF Therapy for Vision Preservation and Restoration

This activity is supported by an educational grant from Genentech, Inc.

Expiration Date: 9/8/2018
Credit Type(s): Physician | Credit: 1.25

Diabetic retinopathy (DR) and diabetic macular edema (DME) are 2 of the most common causes of blindness among working-age people throughout the world. Effective…

go to activity »
Back to the Future:  Clinical Experience with and Access to Lipid-Lowering Agents of the Past, Present, and Future
CMECNECPECDR

Back to the Future: Clinical Experience with and Access to Lipid-Lowering Agents of the Past, Present, and Future

This activity is supported by educational funding provided by Amgen and Sanofi US and Regeneron Pharmaceuticals.

Expiration Date: 8/11/2018
Credit Type(s): CDR / CME / CNE / CPE | Credit: 2

With each passing year we gain new insight and understanding around the clinical utilization of lipid-lowering therapeutic agents. Our historical experience with older…

go to activity »
Rapid Response from Austin: Expanding Options in Type 2 Diabetes Management
CME

Rapid Response from Austin: Expanding Options in Type 2 Diabetes Management

This activity is supported by educational grants from Boehringer Ingelheim Pharmaceuticals, Inc. and Lilly USA, LLC.

Expiration Date: 5/23/2018
Credit Type(s): CME | Credit: 0.75

Approximately 150 million people worldwide have diabetes mellitus and this number is expected to double by 2025. Numerous therapeutic advances have emerged, including…

go to activity »
The Future of the Lipid Panel: An NLA Expert Discussion
CMECECPECNE

The Future of the Lipid Panel: An NLA Expert Discussion

This educational activity is supported by an educational grant from Quest Diagnostics, Inc.

Expiration Date: 4/18/2018
Credit Type(s): CME / CNE / CPE / Participation | Credit: 1.75

Past-President of the National Lipid Association and Editor-in-Chief of the Journal of Clinical Lipidology, Dr. W. Virgil Brown is joined by Drs. Yehuda Handelsman…

go to activity »